Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Solomon

Showing results (471-480 of 524) with videos related to

Pageof 53
Sort By:
Arthritis Research & Therapy|April 28, 2016
Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendationsLeslie R Harrold, George W Reed, Joel M Kremer, et al.
Annals of Internal Medicine|February 16, 2011
Impact of obesity and knee osteoarthritis on morbidity and mortality in older AmericansElena Losina, Rochelle P Walensky, William M Reichmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 18, 2017
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled TrialDaniel H Solomon, Elena Losina, Bing Lu, et al.
Arthritis Care & Research|January 3, 2013
Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseasesVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
Arthritis Care & Research|December 4, 2012
Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the USElena Losina, Alexander M Weinstein, William M Reichmann, et al.
Arthritis Care & Research|November 29, 2011
Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritisVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
BMJ Open|August 9, 2023
Derivation and external validation of a risk score for clinically important declines in health and function among two longitudinal cohorts of women in the mid-lifeDaniel H Solomon, Leah Santacroce, Aladdin Shadyab, et al.
Arthritis Care & Research|October 8, 2021
Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients With Rheumatoid ArthritisSicong Huang, Tianrun Cai, Brittany N Weber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2020
Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategiesVibeke Norvang, Gina H Brinkmann, Kazuki Yoshida, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) studyJohn W Baddley, Kevin L Winthrop, Lang Chen, et al.
Pageof 53

Showing results (471-480 of 524) with videos related to

Sort By:
Pageof 53
Arthritis Research & Therapy|April 28, 2016
Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendationsLeslie R Harrold, George W Reed, Joel M Kremer, et al.
Annals of Internal Medicine|February 16, 2011
Impact of obesity and knee osteoarthritis on morbidity and mortality in older AmericansElena Losina, Rochelle P Walensky, William M Reichmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 18, 2017
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled TrialDaniel H Solomon, Elena Losina, Bing Lu, et al.
Arthritis Care & Research|January 3, 2013
Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseasesVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
Arthritis Care & Research|December 4, 2012
Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the USElena Losina, Alexander M Weinstein, William M Reichmann, et al.
Arthritis Care & Research|November 29, 2011
Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritisVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
BMJ Open|August 9, 2023
Derivation and external validation of a risk score for clinically important declines in health and function among two longitudinal cohorts of women in the mid-lifeDaniel H Solomon, Leah Santacroce, Aladdin Shadyab, et al.
Arthritis Care & Research|October 8, 2021
Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients With Rheumatoid ArthritisSicong Huang, Tianrun Cai, Brittany N Weber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2020
Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategiesVibeke Norvang, Gina H Brinkmann, Kazuki Yoshida, et al.
Annals of the Rheumatic Diseases|July 16, 2013
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) studyJohn W Baddley, Kevin L Winthrop, Lang Chen, et al.
Pageof 53